KKKapil Kalra

Kapil Kalra

*This is an algorithmically generated author record based on publicly available information.

Kapil Kalra has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory lung diseases: pathogenic contributor and therapeutic target

    by Muhammad Afzal, Sami I. Alzarea, Imran Kazmi, Abida Khan, Surya Nath Pandey, Arcot Rekha, Rakhi Mishra, Deepika Raina, Jyoti Maithani Kalra, Kapil Kalra, et al.

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an integral pathogenic factor in inflammatory lung pathologies including asthma, COPD, and lung cancer. As a pro-inflammatory cytokine, GM-CSF triggers the division and stimulation of granulocytes and macrophages, exacerbating the inflammatory response and promoting lung tissue damage. GM-CSF is an essential factor in promoting the production of the corresponding cytokines, levelling the effect of local activity by stimulating the infiltration of immune cells and maintaining chronic inflammation. Therefore, its neutralization in many ways leads to the cessation of the progression and exacerbation of inflammation in the lungs of patients with corresponding pathologies. Inhibitory therapy associated with GM-CSF reduces the number of immune cells and activates them at the inflammatory focus. The use of neutralizing antibodies to treat an acute inflammatory process is promising because they relatively quickly neutralize the effect of pathogenic GM-CSF. However, the immunocyte response can also be inhibited at the level of formation. Therapy with GM-CSF inhibitors can significantly reduce acute inflammation but can lead to adverse changes in the innate immunity of the patient. This review highlights GM-CSF's dual function of GM-CSF as a pathogenic contributor and possible treatment targets.

  • Open Access

    Explainable Machine Learning Using Taguchi-QbD Data for Digital Design Space Mapping of Pregabalin Extended-Release Tablets

    by Deepender, Tarandeep Singh Walia, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, Kapil Kalra, et al.

    This study applied explainable machine learning to published Taguchi-QbD data for pregabalin extended-release tablets to support formulation understanding and digital design space mapping. No new experimental batches were prepared; the analysis used formulation-response data from a previously developed pregabalin extended-release tablet system. A secondary data set containing 16 Taguchi formulations was prepared using six formulation and process variables: lipid material type, lipid quantity, hydrophilic matrix type, hydrophilic matrix quantity, filler type, and compression force. Hardness, friability, and dissolution at 1, 2, 4, and 8 h were selected as modeling responses. Ridge regression, random forest regression, extra trees regression, and Gaussian process regression were evaluated using leave-one-out cross-validation. Model-independent explainability was performed using permutation feature importance, partial dependence analysis, and surrogate decision-tree rules. A desirability-based virtual formulation screening approach was then used to identify high-desirability regions within the original experimental design limits. Dissolution at 2 h and 4 h showed the most useful cross-validated predictive performance, with mean absolute errors of 10.25% and 8.10%, respectively. Explainability analysis identified hydrophilic matrix quantity as the dominant variable controlling early and intermediate drug release, whereas lipid type and lipid quantity were more influential for tablet hardness and late-stage release behavior. Among the original Taguchi formulations, F15 showed the highest observed desirability, although it did not fully satisfy all dissolution criteria. Virtual screening identified high-desirability in silico candidates characterized mainly by high hydrophilic matrix loading and adequate lipid content. The published optimized formulation was positioned within a high-desirability AI-predicted region, supporting consistency between the explainable ML workflow and the original QbD optimization. These findings indicate that small-data explainable machine learning can complement QbD-based formulation analysis by extracting formulation rules and prioritizing design-space regions; however, AI-predicted candidates require experimental confirmation.

  • Open Access

    Machine Learning Modeling of D-Optimal Design Data for Metformin Hydrochloride Orally Disintegrating Tablets

    by Sanju, Suresh Yarlagadda, Vinay Kumar, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, et al.

    Metformin hydrochloride orally disintegrating tablets require an appropriate balance between mechanical strength and rapid disintegration, particularly because the drug is administered at a relatively high dose and has unfavorable taste characteristics. The present study applied machine learning to published D-optimal design data for metformin hydrochloride orally disintegrating tablets to evaluate whether formulation and process variables could predict powder-flow and tablet-performance responses. The dataset contained 30 experimental runs with four inputs: co-processed metformin hydrochloride ratio, co-processed excipient ratio, compression pressure, and excipient brand. Five responses were modeled separately: angle of repose, Hausner’s ratio, Carr’s index, hardness, and disintegration time. Polynomial Ridge Regression, Random Forest, Extra Trees, Gradient Boosting, Support Vector Regression, Gaussian Process Regression, and k-nearest neighbors were compared using leave-one-out cross-validation. Model performance was assessed using mean absolute error, root mean square error, and cross-validated R². Gaussian Process Regression was the best model for Hausner’s ratio, Carr’s index, hardness, and disintegration time, while Support Vector Regression performed best for angle of repose. Tablet hardness and disintegration time were predicted with the strongest performance, with R² values of 0.840 and 0.858, respectively. In contrast, angle of repose was weakly predicted, with an R² of 0.158. Permutation importance and partial dependence analysis indicated that compression pressure and excipient brand were the main contributors to tablet-level responses. The findings show that machine learning can support interpretation of D-optimal formulation data, especially for tablet-performance attributes, while predictions remain limited by dataset size and absence of new external validation.


  • Open Access

    The Impact of Diabetes Mellitus on Fungal Infections: Pathophysiology, Clinical Manifestations, and Treatment Approaches

    by Pallavi Pandey, Supriyo Saha, Vikash Jakhmola, Kapil Kalra

    Diabetes mellitus is known to be a long-term metabolic disorder identified by high blood glucose levels, affects millions of individuals worldwide, and considerably amplifies the risk of infections, including those caused by fungi. Fungal infection is considered a silent killer and the number of cases is increasing globally. This review explores the complex relationship between diabetes and fungal infections, emphasizing the elevated risk and severity of these infections in diabetic patients. Elevated blood glucose levels and impaired immune function in diabetic individuals create an environment favorable to fungal growth, leading to fosters conditions favorable to infections, from minor to severe systemic cases. Commonly occurring fungal pathogens such as Candida, Aspergillus, and dermatophytes are discussed, along with their clinical implications and treatment challenges. The article also includes case studies from diverse geographic regions that underscore the prevalence and severity of fungal infections in diabetic populations. It has been observed that the pharmacokinetics of antifungal agents are greatly impacted by diabetes and cause alteration in drug absorption, distribution, and metabolism. Prevention and management strategies, including strict glycemic control, regular screening, hygiene practices, and patient education, are emphasized to mitigate the risk of fungal infections. This review calls for ongoing research and the development of new antifungal treatments tailored to diabetic patients to improve outcomes and enhance patient care.


  • Open Access

    Simultaneous Estimation of Ciprofloxacin and Tinidazole by U.V Spectrophotometer using a Hydrotropic Solubilization Technique

    by Km. Babita, Kapil Kalra, Neetu Rajpoot, Poonam Joshi, Vandana Pokhriyal

    Advanced, easy and accurate UV spectroscopy technique (I & II) was developed for estimation of Ciprofloxacin and Tinidazole in bulk and tablet dosage form and validated using hydrotropic solubilization techniques. In Method I we focused on solving the simultaneous equation on the basis of absorbance measurement at 270nm and 320nm wavelength of Ciprofloxacin and Tinidazole individually in 2M urea solution which results in enhancement of solubility of CPH and TNZ to about 15 folds as compared to distilled water.Strategy II is lay out idea of Q-analysis in which absorbance was estimated at 288nm (iso-absorptive point) 270nm (λmax of CPH) in 2M urea. Ciprofloxacin and Tinidazole display linearity at chose frequencies and comply with Beer's regulation in the focus scope of 0.2-1.2μg/mL and 10 to 60μg/mL separately. Recovery reads up for CPS and TNZ were completed and rate recuperation of the medications gotten in the scope of 99.2 - 99.6% (Method A) and 98.0-100.8% (Method B) affirming the exactness of the proposed strategy. Both the techniques showed great reproducibility and recuperation with %RSD less than 2. Factual approval of the information shows that the proposed strategies can be effectively applied for the standard examination of medications in business tablets.